Entering text into the input field will update the search result below

Illumina loses EU antitrust probe challenge over Grail acquisition

Jul. 13, 2022 9:10 AM ETIllumina, Inc. (ILMN)By: Dulan Lokuwithana, SA News Editor6 Comments

Illumina headquarters in Silicon Valley

Sundry Photography/iStock Editorial via Getty Images

  • The shares of Illumina (NASDAQ:ILMN) lost ~3% in the pre-market Wednesday after a top European court upheld a decision by the EU’s competition authority to review the company’s $8B acquisition of cancer

Recommended For You

Comments (6)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

bluescorpion0 profile picture
donzoab profile picture
bluescorpion0 profile picture

About ILMN

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Illumina, Inc.
Waters Corporation
Revvity, Inc.
Charles River Laboratories International, Inc.
Bio-Techne Corporation
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.